MediLiVes has brought an opportune moment for a major and much-needed disruption of the current healthcare system. With telemedicine infusion with technology, doctors and patients alike can manage care remotely, increasing efficiency and outcomes.
Afghanistan, Bosnia & Herzegovina, Cayman Island, Democratic peoples Republic of korea (DPRK), Ethiopia, Iran, Iraq, Pakistan, Srilanka, Syria, Trinidad, and Tobago , Tunisia, Uganda, the United States and Yemen.
Medi-Science International Ltd is an official provider and distributor oÿ Medi-Science technoloĀy called Analytical telemedicine system MediLiVes. Medi-Science International Ltd is also the official entity involved in the preparation and execution oÿ the MediLiVes IEO project. It is an innovative company offerinĀ unique, new-Āeneration telemedicine solutions. Telemedicine, based on technoloĀy that enables a patient’s health condition to be monitored ÿrom a distance, is one oÿ the ÿastest-ĀrowinĀ industries in the world.
The versatile nature oÿ our core product means that it can find abnormalities not only in cardioloĀy but also in diabetes, dietetics, civilization diseases, and chronic illnesses.
There are countless examples around the world where comparable achievements have required many years oÿ work. Our effectiveness results mainly ÿrom the conscious use oÿ the latest Microsoÿt technoloĀies such as cloud computinĀ, artificial intelliĀence, and cross-platÿorm soÿtware.
Thanks to numerous visits at scientific and industry conÿerences in The Middle East, London and Europe, Russia, Aÿrica, and Asian countries, United States and many more we have built our position as experts in the telemedicine sector.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Founder-Promethean Dynamics |Certified Blockchain Solutions Architect|Blockchain Advisory Council |Alliance of Blockchain Professionals | Rated on Sep 11, 2019
5
4
5
20%
The medical industry is one of the industries that I believe will experience major disruption in the coming years thanks to DLT. Adding AI into the mix is even better, which is exactly what MediLives is doing. They have really interesting business model and I think this project has loads of potential.
The whitepaper is well written, they have an experienced team and a strong advisory board.
→ Blockchain Advantage - ✅❤️
→ White Paper - ✅
→ Team Composition - ✅
→ Token Economics - - ⛔️
→ Business Model - ⛔️
→ Social Media Presence - ✅❤️
→ Collaborations & partnerships - ⛔️
→ Fund Allocation - ✅
→ Legal Loopholes - ⛔️
→ MVP/ DApp/ Working Product - ⛔️
Advantage - The White paper is clearly written with a macroscopic overview. A good capable team to lead the project.
Disadvantage - Lack of partnerships, unclear go-to-market strategy (business model & focus) and most importantly details about tokenomics is lacking. At this stage they lack an MVP and also no legal team backing it.
You can find my ratings methodology here- https://medium.com/@krishnenduchatterjee/ico-evaluation-investing-a-vc-perspective-for-investment-over-greedy-short-term-returns-433f6f9e13d8
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
